KRAS and neoplasm: This finding was further supported by a genetic approach which has shown that GGTase I deficiency reduces tumor formation and improves survival in mice with K-Ras-induced lung cancer [11], thus further supporting the importance of GGTase I inhibition as a useful strategy to treat cancer, particularly K-Ras-induced cancer.